dc.contributor.author | Pooja Chitneni, Pooja | |
dc.contributor.author | Bwana, Mwebesa Bosco | |
dc.contributor.author | Owembabazi, Moran | |
dc.contributor.author | Neil, Kasey O’ | |
dc.contributor.author | Kalyebara, Paul Kato | |
dc.contributor.author | Muyindike, Winnie | |
dc.contributor.author | Musinguzi, Nicholas | |
dc.contributor.author | Bangsberg, David R | |
dc.contributor.author | Marrazzo, Jeanne M | |
dc.contributor.author | Haberer, Jessica E | |
dc.contributor.author | Kaida, Angela | |
dc.contributor.author | Matthews, Lynn T. | |
dc.date.accessioned | 2022-01-13T08:12:50Z | |
dc.date.available | 2022-01-13T08:12:50Z | |
dc.date.issued | 2020-08 | |
dc.identifier.citation | Geng, E. H., Glidden, D. V., Bwana, M. B., Musinguzi, N., Emenyonu, N., Muyindike, W., ... & Martin, J. N. (2011). Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approach. PloS one, 6(7), e21797. | en_US |
dc.identifier.uri | http://ir.must.ac.ug/xmlui/handle/123456789/1142 | |
dc.description.abstract | Background: Knowledge of STI prevalence and risk factors is important to the development of tenofovir-based pre-exposure prophylaxis (PrEP) and safer conception programming. We introduced STI screening among women at risk for HIV exposure, participating in a safer conception study in southwestern Uganda.
Methods: We enrolled 131 HIV-uninfected women, planning for pregnancy with a partner living with HIV or of unknown HIV-serostatus (2018–2019). Women were offered comprehensive safer conception counseling, including PrEP. Participants completed interviewer-administered questionnaires detailing socio-demographics and sexual history. We integrated laboratory screening for chlamydia, gonorrhea, trichomoniasis, and syphilis as a substudy to assess STI prevalence. Multivariable logistic regression was used to determine correlates.
Results: Ninety-four women completed STI screening (72% of enrolled). Median age was 30 (IQR 26–34) years, and 94% chose PrEP as part of safer conception care. Overall, 24% had STIs: 13% chlamydia, 2% gonorrhea, 6% trichomoniasis, 6% syphilis, and 3% ≥2 STI. STI prevalence was associated with younger age (adjusted odds ratio [AOR] 0.87, 95% confidence interval [CI] 0.77–0.99), prior stillbirth (AOR 5.04, 95% CI 1.12–22.54), and not feeling vulnerable to HIV (AOR 16.33, 95% CI 1.12–237.94).
Conclusion: We describe a 24% curable STI prevalence among women at risk for HIV exposure, planning for pregnancy. These data highlight the importance of integrating laboratory-based STI | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | HHS Public Access | en_US |
dc.subject | Sexually transmitted infection; | en_US |
dc.subject | women | en_US |
dc.subject | PrEP | en_US |
dc.subject | periconception | en_US |
dc.subject | Uganda | en_US |
dc.title | STI prevalence among women at risk for HIV exposure initiating safer conception care in rural, southwestern Uganda | en_US |
dc.type | Article | en_US |